Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

CorMedix Inc (CRMD) had Revenue of $104.28M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$104.28M
Net Income	$108.56M
Cost of Goods Sold	$11.19M
Gross Profit	$93.08M
Operating Expenses	$52.93M
Operating Income	$51.35M
Non-Operating Income/Expense	$1.23M
Pre-Tax Income	$52.58M
Normalized Pre-Tax Income	$52.58M
Income after Taxes	$108.56M
Income from Continuous Operations	$108.56M
Consolidated Net Income/Loss	$108.56M
Normalized Income after Taxes	$108.56M
EBIT	$51.35M
EBITDA	$55.24M
Weighted-Average Shares Outstanding (Basic)	75.93M
Weighted-Average Shares Outstanding (Diluted)	86.21M
Earnings per Share (EPS) (Basic)	$1.42
Earnings per Share (EPS) (Diluted)	$1.26
Balance Sheet Financials
Current Assets	$259.54M
Property, Plant, and Equipment	$4.35M
Long-Term Assets	$491.33M
Total Assets	$750.86M
Current Liabilities	$133.64M
Long-Term Debt	$145.09M
Long-Term Liabilities	$243.09M
Total Liabilities	$376.73M
Common Equity	$374.13M
Tangible Shareholders Equity	$-33.40M
Shareholders Equity	$374.13M
Common Shares Outstanding	78.35M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$80.58M
Cash Flow from Investing Activities	$-311.73M
Cash Flow from Financial Activities	$239.87M
Beginning Cash	$40.76M
End Cash	$49.48M
Increase/Decrease in Cash	$8.73M
Stock-Based Compensation	$10.24M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.94
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.28
Debt to Equity Ratio	0.39
Gross Margin	89.26%
Operating Margin	49.24%
EBIT Margin	49.24%
EBITDA Margin	--
Pre-Tax Profit Margin	50.42%
Profit Margin	104.11%
Free Cash Flow	$80.04M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.39
Receiveable Turnover	0.66
Days Sales in Receivables	136.87
Return on Equity	29.02%
Return on Tangible Equity	-325.06%
Return on Assets	14.46%
Return on Investments	20.91%
Book Value Per Share	$4.78
Free Cash Flow per Share	$0.93
Operating Cash Flow per Share	$0.93

Data from Zacks Investment Research, Inc.